Tag: anti inflammatory therapeutics market size

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Anti-Inflammatory Therapeutics Market Value Growth And Long-Term Outlook

The anti-inflammatory therapeutics market has experienced consistent expansion in its size over recent years. It is projected to expand from $117.28 billion in 2025 to $122.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.3%. This historical growth can be attributed to factors such as the increasing prevalence of arthritis, a rise in inflammatory bowel disease cases, the expansion of hospital pharmacy networks, the adoption of corticosteroids, and the demand for pain management drugs.

The anti-inflammatory therapeutics market size is projected to experience robust expansion in the coming years. This market is predicted to reach a valuation of $152.04 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 5.6%. This anticipated growth is attributable to factors such as the advancement of targeted biologics, the incorporation of artificial intelligence in drug discovery, the proliferation of online pharmacies, the expanding elderly population, and a heightened emphasis on personalized medicine. Key trends anticipated during this period encompass tailored anti-inflammatory treatments, a greater adoption of biologic medications, the development of minimally invasive drug delivery methods, an increase in chronic pain management solutions, and a wider reach for online pharmacy distribution.

Get A Free Sample Report With In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Anti-Inflammatory Therapeutics Market Growth Factors Behind Sustained Expansion

The expanding occurrence of inflammatory bowel disease is anticipated to boost the growth of the anti-inflammatory therapeutics market moving forward. Inflammatory bowel disease (IBD) is a persistent ailment that causes inflammation of the gastrointestinal tract. Anti-inflammatory therapeutics are essential in addressing Crohn’s disease by mitigating inflammation, managing its symptoms, and reducing the necessity for surgery. For example, in June 2023, Crohn’s and Colitis Canada, a non-profit organization based in Canada, reported that 470,000 individuals in Canada are projected to suffer from inflammatory bowel disease (IBD) by 2035, an increase from an estimated 322,600 in 2023. Thus, the rising prevalence of inflammatory bowel disease is propelling the expansion of the anti-inflammatory therapeutics market.

Anti-Inflammatory Therapeutics Market Breakdown By Product Type And Application

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

Anti-Inflammatory Therapeutics Market Industry Trends Fueling Future Revenue Growth

Leading firms in the anti-inflammatory therapeutics market are concentrating on creating cutting-edge biologic treatments to enhance patient results for those suffering from chronic inflammatory ailments. Such sophisticated treatments aim to provide precise immune regulation, improved effectiveness, and superior tolerability when contrasted with traditional options like corticosteroids. As an example, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, and Sanofi, a France-based pharmaceutical and healthcare company, introduced Kevzara (sarilumab). This product is notable as the inaugural and sole anti-inflammatory biologic advised for adult patients diagnosed with polymyalgia rheumatica (PMR) who either show insufficient response to corticosteroids or cannot endure corticosteroid dosage reduction. This innovative IL-6 receptor inhibitor presents a more potent and corticosteroid-reducing treatment alternative, thereby addressing a considerable gap in PMR management and bolstering the standing of these companies within the anti-inflammatory therapeutics market.

Anti-Inflammatory Therapeutics Market Company Landscape And Competitive Strategy

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Co. Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

View The Full Anti-Inflammatory Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Anti-Inflammatory Therapeutics Market Geographic Landscape: Which Region Dominates Industry Growth?

North America was the largest region in the anti-inflammatory therapeutics market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Anti-Inflammatory Therapeutics Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The anti-inflammatory therapeutics market has experienced consistent expansion in recent years, with projections indicating a rise from $117.28 billion in 2025 to $122.27 billion in 2026, reflecting a compound annual growth rate (CAGR) of 4.3%. This historical growth has been driven by several key factors, including a higher incidence of arthritis, an increase in chronic inflammatory bowel diseases, the expansion of hospital pharmacy networks, broader adoption of corticosteroid therapies, and a sustained demand for pain management medications.

The market for anti-inflammatory therapeutics is projected to experience significant expansion over the coming years, reaching an estimated value of $152.04 billion by 2030, with a compound annual growth rate (CAGR) of 5.6%. This anticipated growth during the forecast period is driven by factors such as the development of targeted biologic treatments, the incorporation of artificial intelligence into drug discovery, the growing presence of online pharmacies, the rising number of elderly individuals, and an increased emphasis on personalized medicine. Key trends shaping this period include the emergence of customized anti-inflammatory therapies, a greater reliance on biologic drugs, the adoption of less invasive drug delivery methods, a heightened focus on managing chronic pain, and the widening scope of online pharmaceutical distribution channels.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Anti-Inflammatory Therapeutics Market Industry Drivers: What Is Driving Revenue Growth?

The rising occurrence of inflammatory bowel disease is anticipated to boost the expansion of the anti-inflammatory therapeutics market in the coming years. Inflammatory bowel disease (IBD) represents a chronic condition marked by gastrointestinal tract inflammation. Anti-inflammatory therapeutics are essential for managing Crohn’s disease, as they help diminish inflammation, alleviate disease symptoms, and lower the likelihood of surgical intervention. As an example, in June 2023, Crohn’s and Colitis Canada, a nonprofit organization based in Canada, projected that the number of IBD patients in Canada would reach 470,000 by 2035, compared to an estimated 322,600 in 2023. Consequently, the growing prevalence of inflammatory bowel disease is fueling the advancement of the anti-inflammatory therapeutics market.

Anti-Inflammatory Therapeutics Market Segment Landscape And Growth Potential

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

Anti-Inflammatory Therapeutics Market Growth Trends: What Is Influencing The Future Outlook?

Leading players in the anti-inflammatory therapeutics market are concentrating on the creation of cutting-edge biologic treatments aimed at enhancing outcomes for individuals suffering from persistent inflammatory disorders. These sophisticated therapies are engineered to deliver precise immune system regulation, superior effectiveness, and improved patient tolerance when compared to standard options like corticosteroids. As an example, in February 2023, Regeneron Pharmaceuticals Inc., a biotechnology firm based in the United States, along with Sanofi, a pharmaceutical and healthcare company from France, introduced Kevzara (sarilumab), which stands as the inaugural and exclusive anti-inflammatory biologic recommended for adult patients diagnosed with polymyalgia rheumatica (PMR) who either have an insufficient response to corticosteroids or cannot manage corticosteroid dose reduction. This innovative IL-6 receptor blocker presents a more potent and corticosteroid-reducing therapeutic choice, tackling a considerable unmet requirement in PMR care, thereby reinforcing the market standing of these companies within the anti-inflammatory therapeutics sector.

Anti-Inflammatory Therapeutics Market Competitive Landscape: Who Are The Leading Companies?

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Co. Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

Access The Complete Anti-Inflammatory Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Anti-Inflammatory Therapeutics Market Geographic Distribution And Regional Opportunities

North America was the largest region in the anti-inflammatory therapeutics market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Anti-Inflammatory Therapeutics Market Projected To Reach By 2030?

The market for anti-inflammatory therapeutics has shown consistent expansion in recent years. Projections indicate this market will expand from $117.28 billion in 2025 to $122.27 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.3%. Historically, this growth was driven by factors including the increasing prevalence of arthritis, a rise in inflammatory bowel disease cases, the expansion of hospital pharmacy networks, the uptake of corticosteroids, and the demand for pain management drugs.

The anti-inflammatory therapeutics market size is projected to experience substantial growth in the coming years, with an anticipated expansion to $152.04 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.6%. This expected increase during the forecast period is attributed to several factors, including the development of targeted biologics, the integration of AI in drug discovery, the expansion of online pharmacies, an increasing geriatric population, and a rising focus on personalized medicine. Significant trends foreseen in this period involve personalized anti-inflammatory therapies, an increased adoption of biologic drugs, the development of minimally invasive drug delivery systems, a growth in chronic pain management solutions, and the further expansion of online pharmacy distribution.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

Which Strong Drivers Are Impacting The Anti-Inflammatory Therapeutics Market Growth?

The escalating occurrence of inflammatory bowel disease is anticipated to fuel expansion within the anti-inflammatory therapeutics market moving ahead. Inflammatory bowel disease (IBD) is defined as a persistent condition characterized by inflammation of the digestive system. Anti-inflammatory treatments are vital for managing Crohn’s disease, effectively diminishing inflammation, alleviating its symptoms, and lowering the necessity for surgical intervention. An illustrative example comes from June 2023 data by Crohn’s and Colitis Canada, a Canadian non-profit, indicating that the number of individuals afflicted with inflammatory bowel disease (IBD) in Canada is projected to reach 470,000 by 2035, a rise from approximately 322,600 in 2023. Consequently, the rising incidence of inflammatory bowel disease is a key factor stimulating the expansion of the anti-inflammatory therapeutics market.

Which Segment Types Are Examined In The Anti-Inflammatory Therapeutics Market Segment Study?

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

Which Trends Are Guiding The Direction Of The Anti-Inflammatory Therapeutics Market?

Leading firms within the anti-inflammatory therapeutics market are concentrating on creating groundbreaking biologic treatments aimed at enhancing patient results for those suffering from chronic inflammatory ailments. Such sophisticated therapies are formulated to provide precise immune modulation, superior effectiveness, and improved patient tolerance in contrast to traditional approaches like corticosteroids. An example of this is the introduction of Kevzara (sarilumab) in February 2023 by Regeneron Pharmaceuticals Inc., a US-based biotechnology firm, and Sanofi, a France-based pharmaceutical and healthcare enterprise. This product is the inaugural and sole anti-inflammatory biologic endorsed for adult patients suffering from polymyalgia rheumatica (PMR) who exhibit insufficient response to corticosteroids or cannot endure corticosteroid dose reduction. As a novel IL-6 receptor inhibitor, Kevzara offers a more potent and steroid-conserving treatment alternative, thereby addressing a crucial unfulfilled requirement in PMR care and solidifying the market standing of these companies within the anti-inflammatory therapeutics sector.

Which Players Are Part Of The Competitive Landscape Of The Anti-Inflammatory Therapeutics Market?

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Co. Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

Get The Full Anti-Inflammatory Therapeutics Market Report:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Which Geographic Region Dominates The Anti-Inflammatory Therapeutics Market?

North America was the largest region in the anti-inflammatory therapeutics market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Anti-Inflammatory Therapeutics Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Browse Through More Reports Similar to the Global Anti-Inflammatory Therapeutics Market 2026, By The Business Research Company

Anti Inflammatory Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Non Steroidal Anti Inflammatory Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Anti-Inflammatory Therapeutics Market Evolve From 2026 To 2030?

The anti-inflammatory therapeutics market has seen steady growth in recent years. It is anticipated to expand from $117.28 billion in 2025 to $122.27 billion in 2026, with a compound annual growth rate (CAGR) of 4.3%. This historical expansion can be attributed to the increasing prevalence of arthritis, a rise in inflammatory bowel disease cases, the development of hospital pharmacy networks, the adoption of corticosteroids, and the demand for pain management drugs.

The anti-inflammatory therapeutics market size is anticipated to experience substantial expansion over the coming years. This market is projected to reach $152.04 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.6%. Several factors will contribute to this growth during the forecast period, including the development of targeted biologics, the integration of AI in drug discovery, the expansion of online pharmacies, an increasing geriatric population, and a rising focus on personalized medicine. Key trends anticipated during this period encompass personalized anti-inflammatory treatments, a greater reliance on biologic drugs, the advent of minimally invasive drug delivery methods, an increase in chronic pain management solutions, and the broadening of online pharmacy distribution channels.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Anti-Inflammatory Therapeutics Market?

The anti-inflammatory therapeutics market is poised for growth due to the escalating incidence of inflammatory bowel disease. This chronic ailment, known as inflammatory bowel disease (IBD), leads to inflammation within the gastrointestinal tract. Anti-inflammatory therapeutics play a critical role in managing Crohn’s disease by mitigating inflammation, alleviating disease symptoms, and decreasing the likelihood of surgical intervention. For illustration, data from Crohn’s and Colitis Canada, a non-profit organization based in Canada, indicated in June 2023 that Canada is expected to have 470,000 individuals suffering from inflammatory bowel disease (IBD) by 2035, a rise from an estimated 322,600 in 2023. Consequently, the expanding occurrence of inflammatory bowel disease is a key factor driving the progress of the anti-inflammatory therapeutics market.

Which Segment Areas Are Covered In The Anti-Inflammatory Therapeutics Market Analysis?

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

What Key Developments And Trends Are Impacting The Anti-Inflammatory Therapeutics Market?

Leading companies within the anti-inflammatory therapeutics market are concentrating on developing groundbreaking biologic therapies to enhance treatment outcomes for individuals suffering from chronic inflammatory conditions. These advanced treatments are designed to provide targeted immune modulation, superior efficacy, and improved tolerability compared to traditional options such as corticosteroids. For instance, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, and Sanofi, a France-based pharmaceutical and healthcare company, introduced Kevzara (sarilumab), which is the first and only anti-inflammatory biologic recommended for adult patients with polymyalgia rheumatica (PMR) who either do not respond sufficiently to corticosteroids or cannot tolerate corticosteroid tapering. This novel IL-6 receptor inhibitor offers a more effective and steroid-sparing therapeutic choice, addressing a significant unmet need in PMR management and reinforcing the companies’ presence in the anti-inflammatory therapeutics market.

Which Global Companies Are Actively Competing In The Anti-Inflammatory Therapeutics Market?

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Co. Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

Read the full anti-inflammatory therapeutics market report here:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

What Are The Leading Geographic Regions In The Anti-Inflammatory Therapeutics Market?

North America was the largest region in the anti-inflammatory therapeutics market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Anti-Inflammatory Therapeutics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp

Browse Through More Reports Similar to the Global Anti-Inflammatory Therapeutics Market 2026, By The Business Research Company

Anti Inflammatory Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Non Steroidal Anti Inflammatory Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the anti-inflammatory therapeutics market from 2026–2035 with trusted insights from The Business Research Company

By how much is the Anti-Inflammatory Therapeutics Market expected to grow between 2026 and 2030?

The anti-inflammatory therapeutics market has experienced consistent growth in its size during recent years. It is projected to expand from $117.28 billion in 2025 to $122.27 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 4.3%. This historical expansion can be ascribed to several factors, including the increasing prevalence of arthritis, a rise in inflammatory bowel disease cases, the growth in hospital pharmacy networks, the adoption of corticosteroids, and the sustained demand for pain management drugs.

The anti-inflammatory therapeutics market size is projected to experience significant growth in the coming years. This market is set to expand to $152.04 billion by 2030, driven by a compound annual growth rate (CAGR) of 5.6%. The expansion during the forecast period is attributable to the advancement of targeted biologics, the integration of AI in drug discovery, the growth of online pharmacies, an increasing geriatric population, and a rising focus on personalized medicine. Prominent trends throughout this period encompass personalized anti-inflammatory therapies, an elevated use of biologic drugs, minimally invasive drug delivery systems, a surge in chronic pain management, and the widening distribution through online pharmacies.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

Which Drivers Are Influencing Market Acceleration In The Anti-Inflammatory Therapeutics Market?

The rising occurrence of inflammatory bowel disease is projected to fuel the expansion of the anti-inflammatory therapeutics market. Inflammatory bowel disease (IBD) is a persistent condition marked by inflammation in the gastrointestinal tract. Anti-inflammatory therapeutics are essential in treating Crohn’s disease, as they work to reduce inflammation, manage symptoms, and decrease the need for surgery. For instance, in June 2023, Crohn’s and Colitis Canada, a Canada-based non-profit, reported that the number of inflammatory bowel disease (IBD) sufferers in Canada is expected to reach 470,000 by 2035, an increase from an estimated 322,600 in 2023. This escalating prevalence of inflammatory bowel disease is thus a primary driver for the anti-inflammatory therapeutics market’s growth.

What Segments Are Identified Within The Structure Of The Anti-Inflammatory Therapeutics Market?

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

What Trends Are Driving The Growth Trajectory Of The Anti-Inflammatory Therapeutics Market?

Key companies operating within the anti-inflammatory therapeutics market are concentrating on developing advanced biologic therapies to enhance treatment outcomes for individuals suffering from chronic inflammatory conditions. These sophisticated treatments are designed to deliver targeted immune modulation, improved effectiveness, and better tolerability compared to traditional remedies like corticosteroids. For instance, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology company, and Sanofi, a France-based pharmaceutical and healthcare company, launched Kevzara (sarilumab), which is the first and only anti-inflammatory biologic recommended for adult patients with polymyalgia rheumatica (PMR) who do not respond adequately to corticosteroids or are unable to tolerate corticosteroid tapering. This novel IL-6 receptor inhibitor offers a more potent and steroid-sparing therapeutic choice, addressing a significant unmet need in PMR management and reinforcing the companies’ presence in the anti-inflammatory therapeutics market.

Which Major Firms Are Strengthening Their Position In The Anti-Inflammatory Therapeutics Market?

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Co. Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Which Region Shows The Strongest Potential For Future Expansion In The Anti-Inflammatory Therapeutics Market?

North America was the largest region in the anti-inflammatory therapeutics market in 2025. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Anti-Inflammatory Therapeutics Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp

Browse Through More Reports Similar to the Global Anti-Inflammatory Therapeutics Market 2026, By The Business Research Company

Anti Inflammatory Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Non Steroidal Anti Inflammatory Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Rare Inflammatory Disease Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/rare-inflammatory-disease-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the anti-inflammatory therapeutics market from 2025–2034 with trusted insights from The Business Research Company

What Is The Predicted Size Of The Anti-Inflammatory Therapeutics Industry By 2029?

The anti-inflammatory therapeutics market has shown consistent expansion in recent years. It is expected to expand from $114.71 billion in 2024 to $117.28 billion in 2025, reflecting a compound annual growth rate (CAGR) of 2.2%. This historical growth can be attributed to the prevalence of chronic diseases, an aging population, greater awareness, and government initiatives.

The anti-inflammatory therapeutics market is projected to experience consistent expansion over the upcoming years. This market is predicted to reach $142.15 billion by 2029, achieving a compound annual growth rate (CAGR) of 4.9%. Factors contributing to this growth during the forecast period include pioneering therapies, rising healthcare spending, a greater emphasis on rare diseases, and the development of biologics and biosimilars. Key trends anticipated within this period involve progress in immunotherapy, the application of artificial intelligence (AI) and machine learning (ML) in drug discovery, and the broadening of approved indications.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12861&type=smp

What Major Drivers Are Impacting The Anti-Inflammatory Therapeutics Market?

The rising occurrence of inflammatory bowel disease is anticipated to boost the expansion of the anti-inflammatory therapeutics market in the future. Inflammatory bowel disease (IBD) is defined as a persistent condition characterized by inflammation within the gastrointestinal tract. Anti-inflammatory therapeutics are vital for managing Crohn’s disease, as they work to diminish inflammation, control disease symptoms, and lower surgical risk. As an illustration, data from July 2023, provided by Oxford University Press (OUP), the university press of the University of Oxford, indicated that the incidence of inflammatory bowel disease (IBD) stands at 10.9 per 100,000 person-years, with a prevalence of 721 per 100,000 people. Consequently, the growing prevalence of inflammatory bowel disease is a key factor propelling the anti-inflammatory therapeutics market’s expansion.

Which Segment Categories Are Driving Maximum Growth In The Anti-Inflammatory Therapeutics Market?

The anti-inflammatory therapeutics market covered in this report is segmented –

1) By Drug Class: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Corticosteroids, Anti-Inflammatory Biologics

2) By Indication: Arthritis, Respiratory Diseases, Multiple Sclerosis, Psoriasis, Inflammatory Bowel Diseases, Other Inflammatory Diseases

3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Distribution

Subsegments:

1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Aspirin, Naproxen, Diclofenac, Celecoxib, Indomethacin, Ketoprofen

2) By Corticosteroids: Prednisone, Dexamethasone, Hydrocortisone, Methylprednisolone, Triamcinolone, Betamethasone

3) By Anti-Inflammatory Biologics: Tumor Necrosis Factor (TNF) Inhibitors, Interleukin Inhibitors, Janus Kinase (JAK) Inhibitors, Monoclonal Antibodies, Recombinant Proteins, Fusion Proteins

Which Long-Term Trends Will Play A Crucial Role In The Anti-Inflammatory Therapeutics Market?

Leading companies active in the anti-inflammatory therapeutics market are introducing new and innovative drugs to solidify their market position. For example, in February 2023, Regeneron Pharmaceuticals Inc., a US-based biotechnology firm, and Sanofi, a France-based pharmaceutical and healthcare entity, introduced Kevzara (sarilumab). This medication is the initial and exclusive anti-inflammatory biologic specifically recommended for adult patients with polymyalgia rheumatic (PMR), an inflammatory rheumatic condition, who either do not adequately respond to corticosteroids or are unable to tolerate corticosteroid tapering.

Who Are The Dominant Players In The Anti-Inflammatory Therapeutics Market Today?

Major companies operating in the anti-inflammatory therapeutics market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi-Aventis LLC., Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Company Limited, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Cipla Inc., Zydus Lifesciences Ltd., Lupin Limited, Torrent Pharmaceuticals Ltd.

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/anti-inflammatory-therapeutics-global-market-report

Which Region Is At The Forefront Of Innovation In The Anti-Inflammatory Therapeutics Market?

North America was the largest region in the anti-inflammatory therapeutics market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=12861&type=smp

Browse Through More Reports Similar to the Global Anti-Inflammatory Therapeutics Market 2025, By The Business Research Company

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Non Steroidal Anti Inflammatory Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Cystic Fibrosis Cf Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cystic-fibrosis-cf-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model